4
Changes in Ownership
SYNOPSYS INC Filed Acc 0001249802-26-000010
EXECUTIVE CHAIR sold 49,641 shares at an average $430.68 ($21,379,539)
- EXECUTIVE CHAIR acquired 49,641 shares (option exercise)
- EXECUTIVE CHAIR acquired 22 shares (other)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DE GEUS AART EXECUTIVE CHAIR | 2026-08-31 | Option exercise 10b5-1 | +25,000 | $135.88 | $3,397,000 | 145,421 | D |
| DE GEUS AART EXECUTIVE CHAIR | 2026-08-31 | Sale 10b5-1 | −25,000 | $441.76 | $11,044,115 | 120,421 | D |
| DE GEUS AART EXECUTIVE CHAIR | 2026-08-31 | Other acquisition 10b5-1 | +22 | $360.96 | $7,941 | 120,443 | D |
| DE GEUS AART EXECUTIVE CHAIR | 2026-09-01 | Option exercise 10b5-1 | +24,641 | $135.88 | $3,348,219 | 145,084 | D |
| DE GEUS AART EXECUTIVE CHAIR | 2026-09-01 | Sale 10b5-1 | −24,641 | $419.44 | $10,335,424 | 120,443 | D |
| Derivatives | |||||||
| DE GEUS AART EXECUTIVE CHAIR | 2026-08-31 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −25,000 | 24,641 | D | ||
| DE GEUS AART EXECUTIVE CHAIR | 2026-09-01 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −24,641 | 0 | D | ||
| Open-market sales · 49,641 sh · avg $430.68 · $21,379,539 | |||||||
Loading xslF345X06/edgardoc.xml…